Courses. Meet your regulatory requirements with ISPE Training: Classroom, On-site & On-line. Register Today at ISPE.org/Training

Size: px
Start display at page:

Download "Courses. Meet your regulatory requirements with ISPE Training: Classroom, On-site & On-line. Register Today at ISPE.org/Training"

Transcription

1 Connecting a World of Pharmaceutical Knowledge s Applying Quality Risk Management Basic Computerized Systems Compliance GAMP 5 Biopharmaceutical Manufacturing Processes Cleaning Validation Principles Facility Project Management* HVAC Managing the Risk of Cross Contamination Oral Solid Dosage Forms Pharmaceutical Water Generation Practical Application of Computerized Systems Compliance GAMP 5 Practical Implementation of Process Validation Lifecycle Approach Process Validation in Biotechnology Manufacturing Q7A: Implementing Good Manufacturing Practices Risk Based Approach to GxP Process Control Systems GAMP 5 Risk-Based Verification of Facilities, Systems & Equipment Science and Risk-Based Commissioning and Qualification Sterile Product Manufacturing Facilities Storage, Delivery & Qualification of Pharmaceutical Waters Technology Transfer Turning QbD into a Practical Reality Meet your regulatory requirements with ISPE : Classroom, On-site & On-line Register Today at ISPE.org/

2 Why ISPE? Real World Practice: s present exercises that use current problems and situations common to the industry. Experienced Instructors are subject matter experts and top leaders who have years of experience in the field. Interactive s are taught in an engaging, lively format based on useful actionable information obtain through relevant case studies, exercises and workshops. s provide: Integration and understanding of Regulatory Guidance such as ICH Q7 Active Pharmaceutica Ingredients, ICH Q8 Pharmaceutical Development, ICH Q9 Quality Risk Management, ICH Q10 Pharmaceutical Quality Systems, ICH Q11 Development and Manufacture of Drug Substance, USFDA Process Validation Guidance, Annex 11 and Harmonization. I n-depth understanding of how and why processes work. Current trends and standards, new operational procedures and state-of-the-art technologies you need to improve operations, decrease errors and lower costs. Advantages and disadvantages of different methodologies including alternative approaches for operational procedures and facility design. Many courses include ISPE Guidance documents which provide the practical, "real world" information needed to build on best practices so you can take your work to the next level. Contact ISPE Member Services at or via at ask@ispe.org ISPE Biotechnology Bio Manufacturing Facilities (T31) Biotechnology Basics Biopharmaceutical Manufacturing Facilities Biopharmaceutical Manufacturing Processes (T24) Production Unit Operations drug & biologics Process Validation in Biotech Manufacturing Cleaning, Cleaning Validation Principles (T17) Commissioning and Qualification C&Q as a Risk Management Strategy Facilities, Systems and Equipment Workshop (T48) ISPE

3 Risk-Based Facilities, Systems and Equipment, Science and Risk-based C & Q (T40) GAMP A GAMP Approach to Data Integrity (T50) Application of Computerized Systems Compliance (T11) Basic GAMP 5, Annex 11 / Part 11 Update (T45) Basic Principles of Computerized Systems Compliance Calibration Management Complying with Part 11 - Risk Management: Applying the GAMP Good Practice Guide Electronic Records and Signatures Principles Controls and Automation GxP Process Control Systems (T21) Information Systems Good Manufacturing Practice GMP Auditing for the Pharmaceutical Industry GMP Auditing for the Pharmaceutical Industry (G07) GMP Inspection Approach to Facilities and Equipment GMP Inspection Approach for Laboratory Control Systems GMP Inspection Approach for Materials Systems ISPE

4 GMP Inspection Approach for Packaging and Labeling GMP Inspection Approach for Production Systems GMP Inspection Approach to Quality Systems Government Regulations Q7A: Implementing Good Manufacturing Practices (T30) Standards, Practices and Guides HVAC, HVAC (T14) Manufacturing Applying Quality Risk Management (QRM) (T42) Containment Fundamentals Formulation, Clinical Phases, and Manufacturing Industry Overview: Drug Dosage Forms Managing the Risk of Cross Contamination (T41) Materials Management Operational Economics Operation and Maintenance Oral Solid Dosage Forms (T10) Practical Application of Technology Transfer (T19) Production Control Production Management ISPE

5 Production Scale-up and Optimization Risk-MaPP: What It Is and Why You Need It, Sterile Product Manufacturing Facilities (T12) Technology Transfer Project Management Design and Construction/Installation Facility Project Management (T26)* Quality by Design PQLI: From Concept to Continual Improvement Risk Management and Quality Management Systems Turning QbD into a Practical Reality (T43) Validation Practical Implementation of Process Validation Lifecycle Approach (T46) Process Validation in Biotech Manufacturing (T32) System Validation Water Introduction to Water and Steam (2nd Edition) Pharmaceutical Water Generation (T04) Storage Delivery and Qualification of Pharmaceutical Waters (T23) ISPE *ISPE has been reviewed and approved as a provider of project management training by the Project Management (PMI )

Library Guide: Pharmaceutical GMPs

Library Guide: Pharmaceutical GMPs Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA

More information

In 2001, ISPE issued Baseline Guide Volume

In 2001, ISPE issued Baseline Guide Volume In today s biopharma and pharmaceutical industries, three related, but distinct terms are in common use: commissioning, qualification, and verification. Inconsistent interpretation and application of these

More information

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9

OPER H6001. Pharmaceutical Operations Mgt. APPROVED. Pharmaceutical Operations Management for Engineers. Credits: 5. NFQ Level: 9 Short Title: Full Title: APPROVED Management for Engineers Module Code: OPER H6001 Credits: 5 NFQ Level: 9 Field of Study: Mechanics and metal work Module Delivered in 1 programme(s) Reviewed By: GERARD

More information

GMP Pharma BV. Netherlands

GMP Pharma BV. Netherlands GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization

More information

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation) Los Angeles, CA July 28th & 29th, 2016

More information

ICH Q10 Pharmaceutical Quality System (PQS)

ICH Q10 Pharmaceutical Quality System (PQS) ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives

More information

What is the correct title of this publication? What is the current status of understanding and implementation?

What is the correct title of this publication? What is the current status of understanding and implementation? GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this

More information

ICH Q7 GMP for Active Pharmaceutical Ingredients

ICH Q7 GMP for Active Pharmaceutical Ingredients National University of Singapore Academy of GxP Excellence (NUSAGE) and PharmEng Technology Presents ICH Q7 GMP for Active Pharmaceutical Ingredients Part of the Pharmaceutical Biotechnology Training Courses

More information

Industry Implications of Pharmaceutical Quality ICH Guidelines

Industry Implications of Pharmaceutical Quality ICH Guidelines EIPG General Assembly Industry Implications of Pharmaceutical Quality ICH Guidelines 20 th April 2008 Pharmaceutical Quality Develop a harmonised pharmaceutical quality system applicable across the lifecycle

More information

Validation Consultant

Validation Consultant Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:

More information

GAMP 4 to GAMP 5 Summary

GAMP 4 to GAMP 5 Summary GAMP 4 to GAMP 5 Summary Introduction This document provides summary information on the GAMP 5 Guide and provides a mapping to the previous version, GAMP 4. It specifically provides: 1. Summary of Need

More information

GAMP5 - a lifecycle management framework for customized bioprocess solutions

GAMP5 - a lifecycle management framework for customized bioprocess solutions GE Healthcare Life Sciences GAMP5 - a lifecycle management framework for customized bioprocess solutions imagination at work GE Healthcare s engineering department, Customized Bioprocess Solutions (CBS),

More information

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal

More information

Monitoring the autoclaving process in the pharmaceutical industry

Monitoring the autoclaving process in the pharmaceutical industry Application Description AD/RandC/006-EN Monitoring the autoclaving process in the pharmaceutical industry - Provides independent verification and validation monitoring of the autoclaving process - Enables

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE

More information

1 The quality management system (QMS) is the corner stone of compliance to GMP. The QMS is made up of several documents, that when followed ensures the GMP compliance of the process, facility and company.

More information

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Quality Risk Management 11 November 2011 Galway, Ireland Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle Overview Regulatory

More information

ICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010

ICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010 ICH Q 10 Pharmaceutical Quality System PQS DIA China Annual Meeting, May 2010 Joseph C. Famulare Head of External Relations and Collaboration Pharma Global Technical Operations Global Quality, F. Hoffmann-La

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

The FDA recently announced a significant

The FDA recently announced a significant This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction

More information

This interpretation of the revised Annex

This interpretation of the revised Annex Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation

More information

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005) FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005) Dr.R.MANAVALAN, M.Pharm., Ph.D. Professor and Research Director, Department of Pharmaceutics,

More information

Computer System Validation - It s More Than Just Testing

Computer System Validation - It s More Than Just Testing Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application

More information

Annex 7 Guidelines on pre-approval inspections

Annex 7 Guidelines on pre-approval inspections World Health Organization WHO Technical Report Series, No. 902, 2002 Annex 7 Guidelines on pre-approval inspections 1. General 94 2. Glossary 94 3. Objectives 95 4. Priorities 96 5. Preparation for the

More information

[ABOUT THE AUTHOR. FDA Lifecycle Approach to Process Validation What, Why, and How? PQ Forum. Paul L. Pluta]

[ABOUT THE AUTHOR. FDA Lifecycle Approach to Process Validation What, Why, and How? PQ Forum. Paul L. Pluta] Paul L. Pluta] FDA Lifecycle Approach to Process Validation What, Why, and How? Paul L. Pluta PQ Forum provides a mechanism for validation practitioners to share information about Stage 2 process qualification

More information

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations This paper discusses the nuances of lifecycle validation implementation at contract manufacturing organizations (CMOs).

More information

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance

More information

LIBRARY GUIDE. Online Courses. March 2012

LIBRARY GUIDE. Online Courses. March 2012 LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics

More information

Pharmaceutical Quality Management System: Current Concept

Pharmaceutical Quality Management System: Current Concept Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70

Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70 Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating

More information

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time

More information

Process Validation: Practical Aspects of the New FDA Guidance

Process Validation: Practical Aspects of the New FDA Guidance Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory

More information

Computerised Systems in Analytical Laboratories

Computerised Systems in Analytical Laboratories ECA Certified Computer Validation Manager Course* New EU Annex 11 and Chapter 4 Requirements will be covered Computerised Systems in Analytical Laboratories Foto: DRK The Electronic Analytical GMP : Integrating

More information

Biotechpharma company profile

Biotechpharma company profile Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing

More information

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

World Health Organization Prequalification of Medicines

World Health Organization Prequalification of Medicines Dr André van Zyl World Health Organization Prequalification of Medicines Manufacturers meeting April 2011 Head of Inspections vanzyla@who.int 1 WHO GMP In this presentation: Background and Introduction

More information

Recent Updates on European Requirements and what QPs are expected to do

Recent Updates on European Requirements and what QPs are expected to do Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status

More information

Manufacturing process of biologics

Manufacturing process of biologics Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:

More information

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com

Bachelor s Degree. in Manufacture of Medicinal Products (DT291) Full Time Part Time Online. www.getreskilled.com Bachelor s Degree in Manufacture of Medicinal Products (DT291) Full Time Part Time Online www.getreskilled.com Contents 1. Welcome 2. Program Overview 3. Program Content 4. Core Modules 5. Optional Modules

More information

Risk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems

Risk management is one of the new requirements for. An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems vember 2013 Spectroscopy 28(11) 1 Focus on Quality An Integrated Risk Assessment for Analytical Instruments and Computerized Laboratory Systems A risk assessment is presented for determining the amount

More information

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11 Impact Assessment in a Science & Risk Based Environment R. Legland 11/04/11 Background US GMP s EU GMP s Japan GMP s ICH Q8, Q9, Q10 Guidance ASTM Standard E2500-07 Science and Risk Based Approach to Determine

More information

Validation and Part 11/Annex 11 Compliance of Computer Systems

Validation and Part 11/Annex 11 Compliance of Computer Systems Validation and Part 11/Annex 11 Compliance of Computer Systems by Dr. Ludwig Huber 05 & 06 June 2013, Elite World Hotels, Istanbul - TURKEY Why to attend Computer systems should be validated to demonstrate

More information

Staying Current in Cold Chain Management

Staying Current in Cold Chain Management Staying Current in Cold Chain Management Changes to USP, EU GDPs and Storage and Shipping Practices for Drugs Table of Contents AUTHORS...3 Paul Daniel...3 Piritta Maunu...3 EDITOR...3 John Ferreira...3

More information

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance

ICH Public Meeting. Joseph C. Famulare. October 2, 2006. Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance ICH Public Meeting October 2, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA Office of Compliance The Current State of Pharmaceutical Manufacturing Inability to predict

More information

School of Pharmacy TEMPLE UNIVERSITY

School of Pharmacy TEMPLE UNIVERSITY School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme

More information

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

High Potent Drugs & Containment Technology

High Potent Drugs & Containment Technology High Potent Drugs & Containment Technology Technology Overview & Quality Risk-Based Design Selection Holger Fabritz Head of Quality & Validation Assurance Part 1 Definition High Potent Drugs, OEL & hazardous

More information

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma

Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)

More information

Introduction to Q10 Pharmaceutical Quality System

Introduction to Q10 Pharmaceutical Quality System ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International

More information

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations

More information

Monitoring manufacturing, production and storage environments in the pharmaceutical industry

Monitoring manufacturing, production and storage environments in the pharmaceutical industry Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,

More information

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment

Computerized System Audits In A GCP Pharmaceutical Laboratory Environment IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data

More information

GMP/Regulatory Environment in the

GMP/Regulatory Environment in the GMP/Regulatory Environment in the Latin America Irene Ortiz Barreal, Pharm. D., R.Ph. Pfizer International Affiliate Quality Compliance Regional Leader Latin America/Caribbean April 14, 2011 Discloser

More information

Working with ICH Quality Guidelines - the Canadian Perspective

Working with ICH Quality Guidelines - the Canadian Perspective Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction

More information

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories

More information

GE Healthcare Life Sciences. Validation Services. Compliance support through life cycle management

GE Healthcare Life Sciences. Validation Services. Compliance support through life cycle management GE Healthcare Life Sciences Validation Services Compliance support through life cycle management Validation Services Validation Services is an independent product and service provider within GE Healthcare

More information

Testing Automated Manufacturing Processes

Testing Automated Manufacturing Processes Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

Guidance on Qualification of existing facilities, systems, equipment and utilities

Guidance on Qualification of existing facilities, systems, equipment and utilities QUALIFICATION_EXISTING_EQUIPMENT_FINAL page 1 / 16 1. Acknowledgement...3 2. Introduction...3 3. Scope...4 4. Regulatory requirements...4 5. Guidance...4 5.1 Risk Assessment... 4 5.2 Procedure... 7 5.3

More information

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation Quality Assurance Disclosure for Lilli Møller Andersen No relevant financial relationships exist for any issue mentioned in this presentation Agenda Quality Assurance Quality Management System Quality

More information

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2

New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 New changes to cleanroom & clean air device classifications: ISO 14644 1 & 2 This white paper describes the changes outlined in the Draft International Standard (DIS) editions of ISO 14644-1 and ISO 14644-2.

More information

Clinical database/ecrf validation: effective processes and procedures

Clinical database/ecrf validation: effective processes and procedures TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized

More information

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION 1 US FDA Form 483: A Case Study DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION DEVELOPED BY FRAN RABE 2 Introduction This case study is intended to extract portions of information

More information

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online. www.dpseng.com.sg Principles of Pharmaceutical Facility Design Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new

More information

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical

More information

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1 Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and

More information

Pharmaceutical Quality Systems: US Perspective

Pharmaceutical Quality Systems: US Perspective Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

ICH Q10 - Pharmaceutical Quality System

ICH Q10 - Pharmaceutical Quality System WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,

More information

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control.

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control. SOP Number: SOP -001 Page 1 of 5 4/18/2013 Effective I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control. II. SCOPE All SOP s

More information

Engineering for the new pharma reality

Engineering for the new pharma reality NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have

More information

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management

More information

How CMOs are Turning Their Training Programs into Market Differentiators

How CMOs are Turning Their Training Programs into Market Differentiators How CMOs are Turning Their Training Programs into Market Differentiators How CMOs are Turning Their Training Programs into Market Differentiators A Contract Manufacturing Organization (CMO) has as much

More information

The Quality System for Drugs in Germany

The Quality System for Drugs in Germany The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute

More information

On-Site GMP Training GMP COMPLIANCE TECHNICAL

On-Site GMP Training GMP COMPLIANCE TECHNICAL PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program

More information

Auditing as a Component of a Pharmaceutical Quality System

Auditing as a Component of a Pharmaceutical Quality System Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a

More information

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015 MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This

More information

When printed the document is for reference only and is considered uncontrolled - refer to the Document Control System for the most current version

When printed the document is for reference only and is considered uncontrolled - refer to the Document Control System for the most current version QM-1 SUPPLEMENT QUALITY MANAGEMENT SYSTEMS MANUAL Revision 6 Page: 1 of 6 APPROVED BY: TITLE DATE Electronic Signature on file Quality Director 10/3/15 D. Picciotti Page: 2 of 6 DOCUMENT REVISION HISTORY

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:

More information

With the introduction of GAMP 5, A

With the introduction of GAMP 5, A Online Exclusive from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE January/February 2012, Vol. 32 No. 1 www.pharmaceuticalengineering.org Copyright ISPE 2012 This article presents the case

More information

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services

More information

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP) Nutrition Supplier Meeting, June 30, 2015 Dimitris Catsoulacos Quality Assurance Specialist PRESENTATION OVERVIEW Quality

More information

How to implement a Quality Management System

How to implement a Quality Management System How to implement a Quality Management System This whitepaper will help you to implement a Quality Management System (QMS), based on Good Manufacturing Practice (GMP), ISO 9001 or ISO 13485 within your

More information

2010 Critical Thinker Series

2010 Critical Thinker Series Malaysian Organisation of Pharmaceutical Industries (MOPI) & PharmEng Technology Presents cgmp Case Studies a T rra ini ing i P rrog rram ffo rr cgmp P rro ffe ss ss ionai l ss 2010 Critical Thinker Series

More information

PHARMACEUTICAL REFERENCE STANDARDS

PHARMACEUTICAL REFERENCE STANDARDS PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Hazard Analysis and Critical Control Points (HACCP) 1 Overview

Hazard Analysis and Critical Control Points (HACCP) 1 Overview Manufacturing Technology Committee Risk Management Working Group Risk Management Training Guides Hazard Analysis and Critical Control Points (HACCP) 1 Overview Hazard Analysis and Critical Control Point

More information

Guidance for Industry: Quality Risk Management

Guidance for Industry: Quality Risk Management Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating

More information

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4

ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December

More information

Lean Strategies for Laboratory Testing

Lean Strategies for Laboratory Testing Microrite, Inc. brings you this unique learning experience in Lean Strategies for Laboratory Testing; Part of Microrite s step-by-step webinar series. Lean Strategies for Laboratory Testing erience in

More information

Mobile applications and compliancy: what you should know. March 2016

Mobile applications and compliancy: what you should know. March 2016 Mobile applications and compliancy: what you should know March 2016 1 Mobile applications and compliancy: what you should know Skyping with somebody on the other side of the world via a smartphone, or

More information

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:

Quality Agreement. by and between. Supplier Name. Address: and. Client Name: Address: NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a

More information

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014

Welcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014 Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing

More information

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations Application of Quality Risk Management to Pharmaceutical Operations Eldon Henson, Vice President, Quality Operations Key Topics of Discussion Definition of Quality Risk Management (QRM) Overview of PDA

More information